Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

Integrating molecular modelling methods to advance influenza A virus drug discovery
Hershna Patel, Andreas Kukol
Drug Discovery Today (2020) Vol. 26, Iss. 2, pp. 503-510
Open Access | Times Cited: 40
Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches
Anna Bonomini, Beatrice Mercorelli, Arianna Loregian
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Antiviral activity of iridoid glycosides extracted from Fructus Gardeniae against influenza A virus by PACT-dependent suppression of viral RNA replication
Shanshan Guo, Lei Bao, Chun Li, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 29
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein–Protein Interactions
Serena Massari, Jenny Desantis, Maria Giulia Nizi, et al.
ACS Infectious Diseases (2020) Vol. 7, Iss. 6, pp. 1332-1350
Open Access | Times Cited: 29
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase
Serena Massari, Chiara Bertagnin, Maria Chiara Pismataro, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112944-112944
Open Access | Times Cited: 28
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells
Chiara Bertagnin, Lorenzo Messa, Matteo Pavan, et al.
Cancer Letters (2023) Vol. 571, pp. 216331-216331
Open Access | Times Cited: 9
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization
Anna Bonomini, Tommaso Felicetti, Martina Pacetti, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116737-116737
Closed Access | Times Cited: 3
Discovery of Influenza Polymerase PA–PB1 Interaction Inhibitors Using an In Vitro Split-Luciferase Complementation-Based Assay
Jiantao Zhang, Yanmei Hu, Nan Wu, et al.
ACS Chemical Biology (2019) Vol. 15, Iss. 1, pp. 74-82
Open Access | Times Cited: 26
Antivirals in medical biodefense
Joachim J. Bugert, Friederike I. L. Hucke, Paola Zanetta, et al.
Virus Genes (2020) Vol. 56, Iss. 2, pp. 150-167
Open Access | Times Cited: 26
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization
Beatrice Mercorelli, Jenny Desantis, Marta Celegato, et al.
Antiviral Research (2022) Vol. 204, pp. 105350-105350
Open Access | Times Cited: 15
Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins
Lingxin Hou, Ying Zhang, Han Ju, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 1805-1824
Open Access | Times Cited: 19
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo
Marta Celegato, Mattia Sturlese, Vivian Vasconcelos Costa, et al.
mBio (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Iterative Optimization and Structure–Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity
Han Ju, Lingxin Hou, Fabao Zhao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11550-11573
Closed Access | Times Cited: 12
Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties
Ruifang Jia, Jiwei Zhang, Fangyuan Shi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115275-115275
Closed Access | Times Cited: 6
Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant
Ruifang Jia, Jiwei Zhang, Jian Zhang, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6426-6426
Open Access | Times Cited: 10
Mechanism of the Anti‐Influenza Functions of Guizhi Granules Based on Network Pharmacology, Molecular Docking, and in Vitro Experiments
Ling Wei, Xiang Li, Xiaoyu Liu, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 5
Closed Access | Times Cited: 4
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines
Martina Pacetti, Maria Chiara Pismataro, Tommaso Felicetti, et al.
Organic & Biomolecular Chemistry (2023) Vol. 22, Iss. 4, pp. 767-783
Open Access | Times Cited: 4
Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA–PB1 Subunits Interaction
Ilaria Giacchello, Annarita Cianciusi, Chiara Bertagnin, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 954-954
Open Access | Times Cited: 1
Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo
Anna Bonomini, Jiwei Zhang, Han Ju, et al.
Antiviral Research (2024) Vol. 230, pp. 105980-105980
Open Access | Times Cited: 1
Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles
Jiwei Zhang, Ruifang Jia, Huinan Jia, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means
Olivier Terrier, Anny Slama‐Schwok
Advances in experimental medicine and biology (2021), pp. 195-218
Closed Access | Times Cited: 8
Social, Cognitive, and Emotional Predictors of Adherence to Physical Distancing During the COVID-19 Pandemic
Jean‐Philippe Gouin
(2020)
Closed Access | Times Cited: 6
Thermodynamic and structural characterization of an optimized peptide-based inhibitor of the influenza polymerase PA-PB1 subunit interaction
Kateřina Radilová, Václav Zima, Michal Kráľ, et al.
Antiviral Research (2022) Vol. 208, pp. 105449-105449
Closed Access | Times Cited: 4
structural characterization of the interaction between the C-terminal domain of the influenza polymerase PA subunit and an optimized small peptide inhibitor
Jakub Hejdánek, Kateřina Radilová, Petr Pachl, et al.
Antiviral Research (2020) Vol. 185, pp. 104971-104971
Open Access | Times Cited: 5
A novel N -heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
Jiwei Zhang, Chuanfeng Liu, Ruifang Jia, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top